Microbix Biosystems Inc. (TSE:MBX) Insider Acquires C$204,122.06 in Stock

Microbix Biosystems Inc. (TSE:MBX) insider Microbix Biosystems Inc. purchased 600,359 shares of Microbix Biosystems stock in a transaction on Friday, August 30th. The shares were purchased at an average cost of C$0.34 per share, with a total value of C$204,122.06.

Microbix Biosystems Stock Performance

MBX traded down C$0.01 during trading hours on Friday, reaching C$0.37. The company’s stock had a trading volume of 22,000 shares, compared to its average volume of 62,248. Microbix Biosystems Inc. has a 52 week low of C$0.23 and a 52 week high of C$0.45. The company’s 50-day moving average is C$0.34 and its 200-day moving average is C$0.35. The company has a debt-to-equity ratio of 22.68, a quick ratio of 5.57 and a current ratio of 6.62. The firm has a market cap of C$50.58 million, a PE ratio of 9.25 and a beta of 0.36.

About Microbix Biosystems

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.